Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins

Y Levy; J George; F Fabbrizzi; P Rotman; Y Paz; Y Shoenfeld

doi:10.1097/00007611-199904000-00012

Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins

South Med J. 1999 Apr;92(4):412-4. doi: 10.1097/00007611-199904000-00012.

Authors

Y Levy¹, J George, F Fabbrizzi, P Rotman, Y Paz, Y Shoenfeld

Affiliation

¹ Department of Medicine B, Sheba Medical Center, Tel-Hashomer, Israel.

PMID: 10219362
DOI: 10.1097/00007611-199904000-00012

Abstract

Churg-Strauss vasculitis (CSV) is a systemic vasculitis usually treated with steroids and cytotoxic drugs. Herein, we describe the beneficial effect of intravenous immune globulin (IVIG) in a 50-year-old man with CSV. The IVIG therapy brought a marked clinical improvement, with impressive decline in the titers of antineutrophil cytoplasmic autoantibody.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Antineutrophil Cytoplasmic / blood
Antibodies, Antineutrophil Cytoplasmic / drug effects
Churg-Strauss Syndrome / drug therapy*
Humans
Immunoglobulins, Intravenous / therapeutic use*
Male
Middle Aged
Treatment Outcome

Substances

Antibodies, Antineutrophil Cytoplasmic
Immunoglobulins, Intravenous